Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mirati Therapeutics Inc.

    NASDAQ: MRTX · Real-Time Price · USD
    58.70
    -0.10 (-0.17%)
    At close: Jan 22, 2024, 10:00 PM

    Mirati Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 12.44M 72.09M
    Cost of Revenue
    		 600K 1.78M
    Gross Profit
    		 11.84M -436.5M
    Operating Income
    		 -759.59M -573.18M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -740.36M -578.49M
    Net Income
    		 -740.87M -581.78M
    Selling & General & Admin
    		 239.8M 136.68M
    Research & Development
    		 531.63M 508.59M
    Other Expenses
    		 n/a -5.3M
    Operating Expenses
    		 771.42M 645.27M
    Interest Expense
    		 n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 772.02M 645.27M
    Income Tax Expense
    		 508K 3.3M
    Shares Outstanding (Basic)
    		 56.23M 51.88M
    Shares Outstanding (Diluted)
    		 56.23M 51.88M
    EPS (Basic)
    		 -13.18 -11.21
    EPS (Diluted)
    		 -13.18 -11.21
    EBITDA
    		 -756.66M -571.4M
    EBIT
    		 -758.32M -573.18M
    Depreciation & Amortization
    		 2.93M 1.78M

    Add to Watchlist